R E S E A R C H Open Access
Nurse prescribing of medicines in 13
European countries
Claudia B. Maier
1,2
Abstract
Background: Nurse prescribing of medicines is increas ing worldwide, but there is limit ed research in Europe. The
objective of this study was to analyse which countri es in Europe have adopted laws on nurse prescribing.
Methods: Cross-country comparative analysis of reforms on nurse prescribing, based on an expert survey
(TaskShift2Nurses Survey) and an OECD study. Country experts provid ed country-specific information, which was
complemented with the peer-reviewed and grey literature. The analysis was based on policy and thematic analyses.
Results: In Europe, as of 2019, a total of 13 countries have adopted laws on nurse prescribing, of which 12 apply
nationwide (Cyprus, Denmark, Estonia, Finland, France, Ireland, Netherland s, Norway, Poland, Spain, Sweden, United
Kingdom (UK)) and one regio nally, to the Canton Vaud (Switzerland). Eight countries adopted laws since 2010. The
extent of prescribing rights ranged from nearly all medicin es within nurses ’ specialisations (Ireland for nurse
prescribers, Netherlands for nurse specialists, UK for independent nurse pr escribers) to a limited set of medicines
(Cyprus, Denmark, Estonia, Finland, France, Norway, Poland, Spain, Sweden). All countries have regulatory and
minimum educational requireme nts in place to ensure patient safety; the majority require some form of physician
oversight.
Conclusions: The role of nurses has expanded in Europe over the last decade, as demonstrated by the adoption of
new laws on prescribing rights.
Keywords: Health professionals, Nurses, Prescribin g, Medications, Laws, Reforms, Advanced practice nursing (APN),
Task shifting, Scope of practice
Background
The right to prescribe medications has for long been re-
served to the medical professi on only. This situation has
changed, with an increasing number of c ountries worldwide
having introduced reform s to authorise nurses to prescribe
certain medications [ 1 – 6 ]. The United States of America
(US) and Canada have a long tr adition with nurses working
in advanced practice roles, which includes the right to pre-
scribe medicines [ 7 – 9 ]. Common drivers that led to nurse
prescribing reforms include p hysic ian shortages (e.g. in
rural areas), the rise in chron ic conditions, more interpro-
fessional team work and an inc rease in nursing e ducation
at higher educational institutions [ 1 , 3 , 10 ]. Introducing
new roles for nurses has been referred to as a disruptive
innovation in healthcare [ 11 ]. Advanced nursing roles
have shown to have implications not only for the nurses
and the teams in which they pra ctice and are influenced by
policies and regulatory mechanisms [ 12 , 13 ]. For instance,
changes to scope-of-practice la ws and policies on advanced
educational programmes have shown to facilitate the up-
take of nurse prescribing and o ther advanced practice nurs-
ing roles [ 12 – 14 ].
Nurse prescribing refers to the official right gran ted to
nurses to pres cribe certain medications [ 4 , 15 ]. The ex-
tent of nurse prescribing depen ds on several factors:
first, the groups of nurse s authorised to prescr ibe, which
can range from small, highly specialised groups of nurses
to all professi onal nurses; second, the type of medica-
tions that nurses are allowe d to prescribe, which can
range from all medicines to a restricted set; and third,
the overall legal responsibility, ranging from independent
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License ( http://creativecommons. org/licenses/by/4.0/ ), which permits unrestricted use, distribution , and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain De dication waiver
( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated.
Correspondence: c.maier@tu-ber lin.de ; [email protected]
1
Department of Healthcare Management, Technische Un iversität Berlin H 80,
Straße des 17. Juni 135, 10623 Berlin, Germany
2
Center for Health Outcomes and Policy Research, University of Pennsylvania
School of Nursing, Claire Fagin Hall, 418 Curie Blvd, Philadelphia, PA 19104,
United States of America
Maier Human Resources for Health (2019) 17:95
https://doi.org/10.1186/s12960-019- 0429-6

prescribing to a delegated model under the supervision
of a physician [ 15 – 17 ]. Nurse prescribing has been
shown to be comparable to physici ans ’ prescribing prac-
tices, as measured by the number of medic ations pre-
scribed as well as the types and dose s of the medic ations
chosen [ 6 , 18 , 19 ]. Patients wer e similarly satisfi ed or
more satisfied with nurses than phy sicians [ 18 ]. A
Cochrane syste matic review showed tha t nurses were as
effective in prescribing medicat ions as physicians for a
range of conditio ns including chronic dise ases [ 19 ].
An international survey in ten high-in come countries
(Australia, Can ada, Finland, Ireland, the Netherlands,
New Zealand, Spain, Swede n, the United Kingdom and
the US) showed that the educational and legal condi-
tions varied across countries [ 1 ]. Among high-income
countries worldw ide, Australi a, Canada, New Zea land
and the US are commonly cited as having impleme nted
laws granting the prescr ibing of a wide range of medi-
cines to advanced practice nur ses (APN) with a Master ’ s
degree [ 1 , 2 ]. APN in these countries are authorised to
prescribe all or almost all medici nes within their spe-
cialty. How ever, differences exist in the regulat ion of
nurse prescribing, nam ely if collaborative agree ments
with physicians are require d by law [ 6 , 20 , 21 ]. In
addition, in Australia, Canada and New Zealan d, there
have also been recent deve lopments to grant registered
nurses limit ed prescribing rights [ 21 , 22 ].
In Europe, the United Kingdom (UK) has a long ex-
perience with nurse prescr ibing [ 6 ], where two models
of nurse prescr ibing originated [ 15 , 23 ], inde pendent
and supplementa ry nurse prescribing. While the forme r
model grants the nurses the authority to issu e prescrip-
tions independently including initial prescribing of a
medicine for the first time, the latter model refers to the
continued prescr ibing after a diagnosis and treatment
plan has been made by a physician [ 15 , 23 ]. Rese arch on
nurse prescribing reforms has been limited and mostly
focused on selected topics and indiv idual countries, such
as in the UK and Ireland on prescribing practic es and
safety considerations [ 24 , 25 ] as well as factor s enabling
implementation of reforms in Ireland [ 26 ]. Recently, re-
search in the Netherlands has evalu ated task shifting be-
tween physic ians and nurse specialists with gener ally
positive results [ 27 , 28 ]. Research in the Netherlands
also assessed physician s ’ and nurses ’ views of introdu-
cing nurse prescribing [ 23 ] as well as prescr ibing prac-
tices of nurses in hospit als, which were show n to be
influenced by national policies as well as individual hos-
pital governan ce structures [ 29 ]. From an intern ational,
cross-country pers pective, research on nurse prescribing
reforms and the extent of pres cribing authority of medi-
cines has bee n scarce. One exception is a revie w by
Kroezen et al. [ 1 ]. The review covered 10 coun tries of
which six belong to the Europe an Union (Finland,
Ireland, the Nethe rlands, Spain, Sweden, and the Unite d
Kingdom). It show ed that at the time of data collection,
three countrie s (Finland, Spain, the Ne therlands) were in
the process of introducing legislation , suggesting an up-
date of the current state of these reforms is warran ted.
Moreover, no study to date has systematic ally covered
all countries belongi ng to the EU ’ s single market.
The pu rp os e o f th is st ud y wa s to an al ys e whi ch co un -
tri es in Eu ro pe have i ntro du ce d nu rse pr es cr ibi ng re fo rm s,
the ex te nt of pres cr ib ing an d regu la tio ns in plac e. Co v er-
ing al l coun tr ies b elon gi ng to th e EU ’ ss i n g l em a r k e t i so f
re leva nc e for its fr ee mo ve me nt pr in ci ple ac ro ss bor de rs
wh ich also ap pl ies to he al th prof e ssi on al s. For the nu rs in g
pro fe ssi on , the fi rs t- lev el ed uc at ion as pr of es si on al nu rs e
is auto ma ti ca lly re co gn ise d, ye t no nurs e spec ia lis at i ons
ar e cover ed un de r the EU re gu lati o n [ 30 , 31 ].
Methods
The study was based on an expert survey to identify
which countrie s in Europe have implemented reforms
on nurse prescr ibing of medicines and, in those coun -
tries with reforms, an analy sis of the extent of prescrib-
ing authority, regulatory and ove rsight requirements.
Expert survey to identify countr ies with prescribing
reforms
An expert survey was conducted in 39 countries (Task-
Shift2Nurses Study) in 2015 covering all EU Member
States and countries belonging to the EU ’ ss i n g l em a r -
ket, pl us Aust rali a, Canad a, New Zeal and an d the US.
A total of 93 country expe rts participated (response
rate 85.3%). The s ampling was based on two interre-
lated strategies: snowballing and ne two rk strategies to
counteract the weaknesses as sociated with snowballing
alone, which has been associated with selection bias or
too homogeneo us groups [ 2 ]. The selection process of
the country experts followed two stages: first, five i nter-
national health workforce experts were identified and
contacted to provide names of country experts. In a
second step, the suggested names were reviewed and
contacted if in accordance with a list of pre-defined cri-
teria (e.g. senior position related to nursing either in
academia, at national nursing association, Ministry of
Health, relevant publications on the topic, proficiency
in Engli sh). More details about the method ology are
available elsewhere [ 2 ]. Among the questions covered
i nt h es u r v e yw e r ei fn u r s e sw e r ea u t h o r i s e dt op r e -
scribe medications and related reforms implemented or
ongoing, as of 2015.
Analysis of country reforms on nurse prescribing
Of those countries identified with reforms on nurse pre-
scribing, an in-dept h analysis of laws and policy documents
was performed as pa rt of an Organisation for E conomic
Maier Human Resources for Health (2019) 17:95 Page 2 of 10

Cooperation and Developmen t( O E C D )s t u d y .C o u n t r ye x -
perts were contacted in 2016 for the purpose of the OECD
study on nurses in adva nced ro les of which prescribing of
medicines was one example [ 4 ]. A total of 25 country ex-
p e r t sf r o mt h o s ec o u n t r i e sw i t h nurse prescribing reforms
implemented or ongoing were contacted and 21 partici-
pated (response rate 84%). They provided additional infor-
mation on the laws, the extent of pr escribing rights (e.g. for
which medi cines and health condit ions), e ducation al, reg u-
latory and oversi ght requirem ents in the countries. For the
purpose of th is paper , the countr y experts we re again co n-
tacted in 2019 to inquire if the information provided in
2016 was still up to date. A total of 15 experts participated
in the 2019 round (response rate 60%) and provided up-
dates to pre-filled forms based on the 2016 data collection.
In five cases, there was a lack of clarity on specific issues,
which was then followed up via e-mail or phone calls and
resolved through discussion.
In addition, a literature search was conduc ted with a
search of the peer-reviewe d (PubMed, CINAH L, Google
Scholar) and grey literatu re (websites of Internatio nal
Council of Nur ses, European Federa tion of Nurses,
WHO, OECD, natio nal Ministries of Health). Search
terms covered a set of terms combined with Boolean op-
erators on nur ses (e.g. registered nurse , professional
nurse, nurse speciali st, Advanced Prac tice Nurse, Nurse
Practitioner and other titles and combinations), prescrib-
ing (prescri*) and the nam es of the 28 EU countries plus
Norway and Switzerland.
The an al ys is wa s b ased on them ati c analys es of th e laws ,
poli cy docu ment s and othe r grey ma teri al, focu ssi ng on
the co nten t of the la ws, by- laws an d the educ ati onal an d
re gul atory re quir ements if stip ulat ed in oth er lega l docu -
ment s. The anal yses we re stru ctured ac cord ing to the
gro ups of nurs es auth oris ed to pres cribe , by medici nes
us ed for th e prev enti on or trea tment of ma jor cond itio ns
to asse ss the exte nt of prescr ibin g, diff eren tiat ing betw een
ini tial pr escr ibing (I P) and conti nued pr escr ibing (C P)
onl y. Fina lly, addi tion al requ ireme nts we re anal ysed by
coun try an d grou ps of nurses , incl uding ma ndato ry regis-
tra tion r equi reme nts ( e.g. in a r egistr y), l evel s of physi cian
ov ersi ght and ot her ove rsigh t requ iremen ts. Th e an alys is
was pe rfor med by th e auth or using stan dard ised wo rd ta-
bles ba sed on the surv ey resp onses, co mple mente d wi th
inf orma tion fr om the la ws an d legal do cume nts an d fed
back to the co untr y expe rts as part of th e 2019 ro und
wh ere ex pert s were re ques ted to pr ovide up date s of the
inf orma tion or conf irm th at th e inf orma tion wa s up to
da te.
Results
As of 2019, 13 countries in Europe have laws on nurse
prescribing in place, which apply nationwide in 12
countries (Cyprus, Denmark, Estonia, Finland, France,
Ireland, Netherlands, Norway, Poland, Spain, Sweden,
United Kingdom) and in one regi on in Switzerland in
the Canton Vaud (Table 1 ).
The four nations of the UK an d Sweden were the first
countries in Europe which introduced pres cribing rights
dating back to 1992 and 1994, res pectively. Countries
that followe d were Norway, Ireland and Den mark in
2002, 2007 and 2009. Since 2010, eight additional coun-
tries (including the Canton Vaud, Switze rland) have
authorised specific groups of nurses to prescribe certain
medications. All have adopt ed laws to officiall y grant
nurses prescribing rights , in some case s followed by the
adoption of decre es to define und er which conditio ns
nurses are allowe d prescribe, for what medic ations and
the regulatory requiremen ts.
The countries vary conside rably in the groups of
nurses tha t are authorised to prescr ibe and their educa-
tional requirement s: a first group consists of countries in
which the prescribing skills and competencies are part
of the nurses ’ education, e.g. Master ’ s or Bachelor ’ s de-
grees or specific nur se specialisations . Hence, the pre-
scribing skills and competencies are directly integra ted
in these curricula, e.g. ANP Master nurses in Cyprus,
Nurse Specialists with APN degree in the Ne therlands,
Public Health Nurses in Norway, nurses with Master ’ s
and Bachelor ’ s degree in Poland, family nur ses in
Estonia; and nurses with a Bachel or ’ s degree in Spain.
Since courses on pha rmacology and pharmaco therapy
are routinely part of these curricul a, it was only in a few
cases possible to single out how many Europe an Credit
Transfer System s (ECTS) points are allocated spe cifically
on skills and compe tencies related to the prescr ibing of
medicines. For instance , in Cyprus, the curriculum of
APN Master-le vel nurses comprises advanced pharma-
cology and pharmacothera py of approx. six ECTS. In
Denmark, prescr ibing is taught as part of a 30 ECT S
“ cluster ” on medical treatm ent and therapy. In the
Netherlands, RNs with a specialisation in diabetes and
RNs with a specialisation of lung care are required to
have a minimum of 2.5 ECTS on prescribing in their
curriculum [ 32 ].
Second, some countries have set up a separate edu ca-
tional pathway spe cifically on nurse prescribing, hence,
additional educational cour ses which lead to a title as
nurse prescriber or similar. The countries are Finland,
Ireland and the UK. Th e UK has introduced two models
of prescribing, independent and supplementary pre-
scribers. Irelan d and Finland have established one role.
Educational require ments vary, they range between
typically 30 to 45 UK credits in the UK, 20 to 40 ECTS
in Ireland and mandatory 45 ECTS in Finland. In 2019,
the UK Nursin g and Midwifery Counc il has published
new standards for the po st-registration pro grammes
which apply since Septe mber 2019 [ 46 ].
Maier Human Resources for Health (2019) 17:95 Page 3 of 10

France and the Swiss Canton Vaud are in the process
of implementing the 2017 laws on nur se prescribing,
pending the agree ment of formularies and othe r mini-
mum requirements as a prerequisite for nur ses to offi-
cially being authorised to prescribe medicines.
Extent of prescribing rights
Table 2 shows the exten t of prescribing rights by coun-
try. The countries vary considerably in the number of
medicines which nurses are officially allowed to pre-
scribe, for which dise ases and the type of prescribing.
The type of prescribing refers to initial and continued
prescribing, of which the former is the right to newly
prescribe medic ines, whereas the latter refer s to follow-
up prescriptions after the diagno sis and first pres cription
has been issued by a physician .
Thre e of th e 13 co untr ies ha ve gran ted fu ll or near ly fu ll
pres crib ing ri ghts to a sp ecifi c gro up of nurs es. Th e coun -
tri es are Ir elan d (nur se pres cribe rs), th e Neth erla nds
(n urse spec iali sts) an d the UK (i ndep ende nt nurs e pre-
scri bers ). Thes e groups o f nurs es are by law al lowe d to
pres crib e any me dici ne with in thei r spec ialty . In the U K
and Ir elan d, the exte nt of presc ribi ng was expa nded gr ad-
uall y over time . In the UK , the l aw was ch ange d in 20 06
auth ori sing inde pend ent pre scri bers full ac cess to th e Brit-
ish Na tional F ormula ry gran ting the same pr escr ibin g
righ ts as for phys ician s, and subs equent ly in 2012 to cov er
cert ain co ntro lled drug s [ 16 ]. In Ir elan d, nurs e pr escri bers
can pr escr ibe a full se t of med icine s sinc e 2007 , inclu ding
cert ain co ntro lled drug s. In the Ne therla nds, an i niti all y
time -li mited la w was int rodu ced in 20 12, lin ked to a na-
tio nwide eval uatio n. The l aw gran ted nu rse sp ecia lis ts
with a Ma ster ’ s degree AP N full pr escr ibi ng righ ts withi n
Table 1 Nurse prescribing laws, years of adoption and groups of nurses authorised to prescribe medications, 13 countries
Year first
adopted
Country Regulation Group(s) of nurses authorised to prescribe (qualification requirements)
1992 UK Medicinal Products: Prescription by
Nurses etc. Act 1992
(i) Independent prescribers (full prescribing rights since 2006; including certain
controlled drugs since 2012, course on independent nurse prescribing required
(NMC approved post-registration prescribing programme e.g. v200 or v300
course, length varies, e.g. 30 – 45 UK credits, typically 6 months; as of September
2019, new standards apply), this includes Community Practitioner Nurse Pre-
scribers (CPNP) with prescribing rights according to a formulary (e.g. V100 or
V150, e.g. 10 UK credits), (ii) Supplementary prescribers since 1992 (limited pre-
scribing rights, approved course as a supplementary prescriber)
1994 Sweden Law RN (Bachelor from university or university college, 180 ECTS)
2002 Norway Law Public health nurse specialisation (Bachelor, plus 60 ECTS)
2007 Ireland Pharmacy Act, Statutory Instrument No.
201/2007 on Medicinal Products
Nurse prescriber: RN plus additional, approve d educational programme (range 20
to 40 ECTS for nurse prescriber certificate or higher if Master APN programme)
2009 Denmark Order 1219 of 11/12/2009 delegation of
reserved procedures
RN (Bachelor, of which 30 ECTS “ cluster ” on medical treatment, including
prescribing)
2010 Finland Decree 1088/2010 on Prescriptions Nurse prescriber: RN (Bachelor, with postgraduate education in prescribing (45
ECTS)
2012 Netherlands Decree, December 21/2011 Nurse specialist ( Verpleegkundig Specialist ) (Master APN, 120 ECTS)
2012 Cyprus Nursing and Midwifery Law, Annex III,
2b) V
APN nurse (Master APN degree with specialisation in Midwifery, ICU, Mental
Health, Oncology, Community health). Advanced pharmacology (6 ECTS) is part
of the Master APN programme
2014 Netherlands Decree of 2014 Diabetes, lung, oncolog y nurses (Bachelor, and completion of pharmacothe rapy
course at a University of Applied Science, e.g. for diabetes and lung nurses,
curricula comprise minimum of 2.5 ECTS on prescribing
2015 Poland Ordinance of 28/10/2015 on
prescriptions issued by nurses and
midwives
Two-tiered: RN with (i) Master and (ii) Bachelor ’ s degree
2015 Spain Royal Decree 954/201 5 of 23 October RN (Bachelor with min. 1 year work experie nce; or additional training in
prescribing if < 1 year experience)
2016 Estonia Health Services Organization Act 2016 Family nurse ( pereõde ) if working with a family doctor ( pereast ) with completed
training of 120 hours (clinical pharmacology, approved by the Agency of
Medicines)
2017 France Act 2016-41 on the modernisation of
the health system
Nurse ( “ Medical auxillaires ” )
2017 Switzerland
(Vaud)
Article 124b of Public Health Act 800.01 Nurse specialist (Master) ( “ Infirmier practicien spécialisé ” )
ANP advanced nursing prac tice, APN advanced practice nurse, CPD continuous professional develop ment, RN registered nurse, sources: [ 16 , 32 – 45 ]
Maier Human Resources for Health (2019) 17:95 Page 4 of 10

thei r spec ialty . Afte r a gene rall y posi tive ev alua tion, th e
time -li mited na ture o f the law wa s chan ged to un limi ted
dura tio n in Sept embe r 20 18 [ 27 ].
In th e rema inder coun trie s, th e exte nt of pr escri bing is
limi ted, ei ther in the numb er of medi cines that nu rses ar e
by law al low ed to pr escri be or in the ty pe of pres crib ing,
al lowing pr ima ril y or excl usive ly cont inued pr escr ibing . In
the Net herl ands (Bac helo r nurses wi th a spec iali sati on in
ei ther diab etes , lun g or oncolo gy), No rway (pub lic he alth
nurs es), Po land (M aste r lev el) and Sw eden (Bac hel or
le vel), nu rses ar e autho rise d to in itial ly pres crib e cert ain
medi cine s from a l imite d set of me dici nes (Tab le 2 ). In
the Neth erla nd s, th e thre e Bachel or-l evel nurs e spec ialis a-
tio ns are auth oris ed to initi ally pr escri be a limit ed numbe r
of med icine s with in their sp ecia lty (p resc ript ion- only
medi cati ons) , afte r a di agno sis has be en made b y a phys-
ic ian, an d as spec ified withi n prot ocol s and st anda rds. In
Norw ay, publ ic heal th nurs es work in chi ld heal th clin ics
and fr equent ly in scho ols or yout h health c entr es wher e
they pr ovi de heal th counse llin g incl udi ng on sexu al health
and pr escr ibe cont race ptive s [ 47 ]. Pu blic he alth nu rses
can of fici all y prescr ibe al l contr acep tive s for al l wome n
Table 2 Extent of nurse prescribing, by group(s) of nurses and country
Prescribing rights by major areas and conditions (IP = initial prescribing, CP = continued prescribing only)
Country Name/title of
nurses
Vaccines Contraceptives Chronic
conditions
Acute illnesses Pain medication Other
Full prescribing rights (within specialty)
Ireland Nurse
prescriber
1
IP IP IP IP IP IP
Netherlands
Nurse
Specialist
2
IP IP IP IP IP IP
UK Independent
prescriber
1
IP IP IP IP IP IP
Limited prescribing rights
Denmark Registered
Nurse
3
CP CP CP CP CP CP
Estonia Family nurse
( pereõde )
– CP (hormonal
contraceptive)
CP (diabetes,
hypertension)
CP (acute cystitis,
nitrofurantoiin)
––
Finland Nurse
prescriber
IP (influenza,
hep.,
varicella^)
IP (hormonal
contraceptive^#)
CP (asthma,
dyslipidemia,
T2D,
hypertension)^
IP (pharyngitis)^,
CP (UTI)^
IP (e.g. local
anaesthetics)^
–
Netherlands
Diabetes, lung,
oncology
nurses
–– IP (diabetes,
oncology, lung
diseases)
– IP (oncology) –
Norway Public Health
Nurse
IP IP (including
IUD)
a
–– IP (adrenaline for
allergic reaction,
local anaesthetics)
IP (sterile
equipment for IU,
implants, STD kits)
Poland RN (Master) – IP
(gynaecological
drugs)
IP (asthma, e.g.
bronchodilators)
IP (throat, ear,
sinus, UTI)
IP (analgesics,
locally acting
anaesthetics)
IP (anti-emetics,
anti-parasitic, IV
infusion fluids)
Poland RN (Bachelor)
4
– CP (as above) CP (as above) CP (as above) CP (as above) CP (as above)
Spain RN (Bachelor)
5
IP (according
to vaccination
schedule)
IP (emergency
contraception)
CP CP CP IP (OTC)
Sweden RN (Bachelor) –– – IP (throat, mouth,
dermatological
disease, GI, UTI)
IP (pain
management)
–
UK Supplementary
prescriber
CP CP CP CP CP CP
Cyprus, France, Switzer land (Vaud): not listed because no information availabl e on the medicines/formulary, IP initial prescribing (prescribing right of a new
medicine/product), CP continuous prescrib ing (follow-up prescribing after first pres cription issued by physician), n/r not reported (in the law/regulations, “ - “ not
authorised to prescrib e any medicine/produc t in the area, n/a no information availab le, OTC over-the-counter medic ines, Hep . hepatitis, UTI urinary tract infection,
GI grastrointestinal.
1
Initial prescribing rights of all medici nes falling within nurses ’ specialty, restricti ons and additional require ments apply to contro lled drugs
(e.g. UK: controlled drugs except for cocai ne, dipipanone or diamorphine for treating addiction ),
2
Netherlands = initial prescribing rights of all medicines falling
within nurses withi n nurse specialists ’ speci alty, Cyprus = details on the types of medicines/subs tances not (yet) specified in law; ^not for children under the age
of 12, #not for women under age 35,
a
only for women over 16 years of age,
3
Denmark = continued prescribing accord ing to local frame prescriptions and in a
delegated model,
4
Poland: prescribing rights accord ing to formulary of 12 groups of m edicines,
5
Spain: prescribing rights granted to all RN with minimum 1 year
work experience; for RN with less than 1 year work experi ence, additional training required
Maier Human Resources for Health (2019) 17:95 Page 5 of 10

ag ed 16 year s and over. In o ne stud y, publi c heal th nurses
wro te more pres cri ption s than ph ysi cians f or youn g
wome n aged 17 – 18 years [ 47 ].
A mix of initial and contin ued prescribing ex ists in
Finland and Spain; it includes initi al prescriptions of vac-
cines and contraceptives in F inland and Spa in and follow-
up medications for highly prevalent chronic and acute c on-
ditions. In Denmark (Bachelor), Estonia (family nurse),
Poland (Bachelor) and the UK (supplementary pre scribers),
nurses are authorised to perfo rm continued prescribing, ac-
cording to patient management plans and in a delegated
model.
No information on the details of prescribing rights was
identified for Cypru s, France and the Canton Vaud
(Switzerland). In Cyprus, there is no information pro-
vided in the 2012 law on what medicines the Master
APN nurses are allowed to prescr ibe. The law sta tes that
medicines from a list can be prescribed by nurses, but
with no furthe r information. In Fr ance and Vaud, due to
the adoption of the laws in 2017, developments are on-
going to specify which medic ations nurses will be able to
prescribe.
Regulatory and oversight requir ements
All countries have define d regulatory requirements as a
pre-condition for nurses to prescribe medic ations
(Table 3 ). The reason is the highly specialise d nature of
prescribing. The majo rity of countries requi re some
form of additional registratio n as a prescriber in a regis-
try or a prior authorisation by a competent authority .
Several countries added additional regu latory require-
ments, e.g. in Ireland, UK and Finland, nurse prescribers
receive a uniq ue ID number to facilita te the identifi ca-
tion of who prescribes what medic ation. In addition,
most countrie s require some form of official authorisa -
tion, contract, collaboration, agree ment or offi cial super-
vision by an individual physician (Denmark, Estonia,
Finland, Ireland, Spain , UK).
Discussion
This study show s that in Europe, certa in groups of
nurses are offi cially authorised to prescribe medications
in 13 countries (nation wide in 12 countries and in one
region in Swi tzerland, Canton Vaud). Th e majority of
the reforms have been introduced over the past decad e.
Since 2010 alon e, eight of the 13 countrie s newly intro-
duced nurse prescribing (Finland, Netherlands , Cyprus,
Estonia, Poland , Spain, France and the region Vaud in
Switzerland). Hence, nur se prescribing has been a recent
development in several countrie s in Europe. The ext ent
of prescribing rights varies considerably, with three
countries (Irel and, Netherlands, UK) grantin g certain
groups of nurse s (nurse prescri bers, nurse specia lists, in-
dependent nurse pres cribers, respectively) almost full
prescribing authority within their specialty. In the other
countries, the number of medicat ions is restricted, de-
fined in a formu lary or can be prescribed only after an
initial prescription has been made by a phy sician. All
countries have regul ated the conditions under which
nurses are allowed to prescribe; the majority require
additional registra tion in the prescribing func tion, some
form of physician ove rsight and other mea sures to en-
sure patien t safety.
The study face s several limitation s. First, it has exclu-
sively focused on nurse prescribing; howe ver, some of
the countrie s have also introd uced prescribing for other
non-medical professio ns, such as midwives or pha rma-
cists. Second, while the article prov ides an overview of
the groups of nurses and ext ent of prescribing rights, the
exact types and dose s of medicines were not covered in-
depth and should be investigated in future research.
Third, information on educa tional requirements for
nurse prescri bing was difficult to obtain, parti cularly for
countries where nurse prescribing is integra ted in basic
or advanced educatio nal programmes.
The fi ndin gs are la rgel y cons isten t with pr eviou s re-
sear ch [ 1 , 3 , 4 ] and pro vi de an upda te with mor e
Euro pean co untr ies cover ed and rece nt reform s incl uded.
Whi le seve ral stud ies in the pa st have fo cuse d on Angl o-
Saxo n coun trie s, with Irel and an d the UK f requ entl y cov-
er ed in rese arch [ 10 , 15 ], this st udy has en abl ed to cove r
more E uropea n countr ies. Th is stud y sh ows that the ex-
tent of nu rse pres cribi ng vari es cons ider abl y acro ss the
coun trie s stud ied an d for sp ecifi c group s of nurs es wi thin
thre e coun tri es (Net herlan ds, Po land , UK), wh ich is con-
sist ent wi th th e prev ious lit erat ure (i bid) . Most co untr ies
in thi s stud y rest ricted pr escr ibing ri ghts to a li st of medi -
ci nes with re gulat ory requ irem ents inc ludi ng phys ician
ov ersi ght. In pr eviou s rese arch , du e to the diff eren ces in
coun try co verag e, whic h covere d six Eu ropean coun tries
(Fin la nd, I re land , Net he rlan ds , Spa in, S we den, UK ) a nd
Aust rali a, Cana da, New Zea land an d th e Un ited Sta tes,
the f indi ngs sho wed high er lev els pr escr ibing ri ghts and
inde pend ence in pr escri bing , e.g. for adva nced pr acti ce
nurs es [ 1 , 17 ].
The findings of this study show that the re are high
variations in the educational requirements, rangin g from
Bachelor level (e.g. Denmark, Spain, Sweden) to Master
level degrees (e.g . Cyprus, Netherlands, Poland ). There
was no obvious link betw een the extent of prescr ibing
rights and the length and level of training across the
countries. In the three countries with almo st full pre-
scribing rights, educational requirement s also varied. In
the Netherlands, nurse specialists are require d to hold a
Master ’ s degree (120 ECTS) as a prer equisite to pre-
scribe medicines. In Ireland and the UK, the competen-
cies are taught in prescriber course s that are approved
by the competent authoritie s, but the length varies and a
Maier Human Resources for Health (2019) 17:95 Page 6 of 10

Master ’ s degree is not require d. There is a paucity of re-
search link ing the educational requirement s with pre-
scribing practic es, the quality of pres cribing and patien t
outcomes. While previous research has analysed the as-
sociation of higher nurse edu cation (e.g. higher propor-
tion of Bachelor-level nurses or a higher proportion of
professional nurse s among all nur ses) with improv ed pa-
tient outcomes and mor tality [ 48 , 49 ], no resea rch was
identified on the asso ciation between qualification and
prescribing outcomes.
The reforms introducin g nurse prescribing in 13
countries span different health systems, educational
systems and geographic lo cations across Europe, in-
cluding predominantly soci al health insurance (France,
Netherlands) and Beveridge models (e.g. UK, Ireland).
The reasons of introducing these reforms and new
laws have not been systematically investigated across
countries. Previous research suggests several potential
drivers, including increasing patient needs and vol-
ume, higher education of n urses, high er workloads
among physicians, inefficient division of work and
high costs, among others [ 17 ]. Other research identi-
fied the roles, skills and competencies of individual
prescribers, professional boundaries, organisational
and institutional contexts as potential drivers or bar-
riers [ 12 , 13 , 50 ]. In Ireland, several facilitating factors
were identified as having contributed to the successful
implementation o f nurse prescribing: strong advo cacy
by the nursing profession, planning for nurse educa-
tion and practice, support for multiprofessional teams
and supportive government action [ 26 ]. Overall, it ap-
pears that the interplay of different factors, including
Table 3 Regulatory and oversight requirements
Country Group of nurses Registration/
authorisation
Physician oversight officially
required? (e.g. collaborative
agreement)
Other regulatory requirements (e.g. protocols, employer-
level requirements)
Cyprus APN Yes (authorisation from
competent authority)
n/r n/r
Denmark RN No Formal collaboration with a
physician
Individual frame prescriptions with physician required
Estonia Family nurse
( pereõde )
Yes (Health Board,
Healthcare Workers ’
Registry)
Required to work with a
family physician
No
Finland RN Yes Authorisation by a physician Employment with municipal health center; ID number with
National Supervisory Authority for Welfare and Health
Ireland Nurse prescriber Yes (An Bord Altranais) Collaborative agreement
with a physician required
Employment in healthcare setting, personal identification
number (PIN)
Netherlands Nurse specialist Yes (nurse specialist
registry)
No No
Diabetes, lung,
oncology
specialist nurses
No (not legally required,
but voluntary
registration possible)
No Following protocols and after initial diagnosis by a
physician
Norway Public health
nurse
Yes (National registry of
healthcare professions)
No Formal documentation of prescriptions (as any other
profession), listed in central registry for prescriptions logs
Poland RN (Master) No No No
RN (Bachelor) No Continuous prescribing
only, after initial diagnosis
by physician
No
Spain RN (Bachelor) Yes (regions in charge of
issuing certificates on
prescribing)
Yes, physician supervision For certain medicines, prescribing rights to be defined in
protocols and clinical guidelines, to be developed by the
Medical and Nursing Councils and MoH
Sweden RN (Bachelor) Yes (prescribing code at
Board of Health and
Welfare)
No (e.g. if employed as
district nurse, works
independently)
Employment with county council, primary, home health or
elderly care
UK Independent
prescriber
Yes (annotation in
registry as independent
prescriber)
Prescribing partnership with
physician required
Support from employing organisation, personal
identification number
Supplementary
prescriber
Yes (annotation as
supplementary
prescriber)
Clinical management plan,
prescribing partnership with
physician
Support from employing organisation, ID number,
continued prescribing of medicines listed in individual
clinical management plan agreed between patient,
physician and supplementary prescriber
APN advanced practice nurse, MoH Ministry of Health, n/r not reported (in law/regulati on), RN registered nurse. France, Canton Vaud (Switze rland): no
information available
Maier Human Resources for Health (2019) 17:95 Page 7 of 10

nurses ’ prescribing skills and education, organisational
factors as well as government, stakeholder and policy
support determine the implementation process. More-
over, reforms appear to take time. In the thre e
countries in our study that grant almost full prescrib-
ing rights to specific groups of nurses (Ireland,
Netherlands, UK), the policy process was lengthy and
evolved over time. In Irela nd and the UK, the extent
of prescribing rights were i nitially limited and grad-
ually expanded over time in line with generally posi-
tive evaluations [ 15 ].
One dr iver oft en refe rred to in Euro pe is the high er edu-
cati on of nu rses in line wi th the Bol ogna cy cle [ 17 , 51 , 52 ].
This may expl ain th e occ urre nce of i nfor mal pres crib ing
prac tic es amon g nurs es wh ich pa ved th e way towa rds fo r-
mal ising nu rse pr escr ibi ng, as re port ed in th e Neth erland s
and Sp ain [ 53 , 54 ]. In the Neth er land s, this ar gume nt was
st rong in th e pol icy deb ate on wh ethe r to intr oduc e a law;
cont rove rsia lly de bate d betwee n the me dical an d nurs ing
asso ciat ions [ 53 ]. Ov eral l, ther e is a lac k of syst ema tic
cr oss- coun try re sear ch on the ro le of var ious infl uenc ing
fact ors ac ting as ba rrie rs or fa cilit ator s to th e intr odu ctio n
of nu rse pr escr ibi ng. In pa rti cular, m ore re sear ch is
need ed on wh y nurs e pr escr ibi ng laws ha ve bee n adopt ed
in the 13 Eu ropean co untr ies and no t othe rs.
In three of the 13 countries, the impl ementation of the
laws is ongoin g, pending the adopt ion of regulatory de-
crees and capacity buildin g in education. France an d the
Canton Vaud have in common that the laws have been
recently adopt ed in 2017. In Cyprus, the ye ar of adop-
tion was 2012 . In Cyprus, there is no evidence of nur se
prescribing officially taking place in practice, as no indi-
vidual request has been made to authorise prescr ibing
rights.
The fact that to date 13 countries belon ging to the
EU ’ s single market grant certain groups of nurse s pre-
scribing rights demonstrates that further cross-c ountry
research is required from an EU perspective. Resear ch
should foc us on commonalitie s and differences in pre-
scribers ’ edu cation across Europe , country variatio ns in
prescribing practic es as well as the extent of prescr ibing
rights and outcomes on specific patien t groups. More-
over, with the increase in health professional mobility
across Europe , including nurses, a tim ely monitoring of
nurses with prescribing rights is war ranted as to avoid
skills mismatches when movin g borders [ 55 – 57 ].
Conclusions
A total of 13 countries in Europe have laws on nurse
prescribing in place, of which the majority adopted
laws over the p ast decade, suggesting a recent trend
expanding the roles of nurses in these countries.
The extent of prescribing rights varies considerably,
with three countries grant ing full prescribing rights,
whereas the majority of countries have restricted
prescribing rights, particularly those with recent re-
forms. From an EU perspective, future cross-country
research is required to monitor the education, pre-
scribing practices and mobility patterns of nurses
with prescribing qualifications.
Abbreviations
APN: Advanced practice nurse; CP: Continued prescribing; CPD: Continuous
Professional Development; CPNP: Community Practitioner Nurse Prescribers;
Dir.: Directive; ECTS: European Credit Transfer System; EU: European Union;
GI: Gastrointestinal; Hep.: Hepatitis; ICU: Intensive care unit; ID
number: Identification Nu mber; IP: Initial prescribing; IUD: Intrauterine device;
MoH: Ministry of Health; n/a: No information available; n/r: Not repo rted;
NMC: Nursing and Midwifery Council; OECD: Organisation for Econom ic
Cooperation and Develop ment; OTC: Over-the-counter medicines;
PHC: Primary health care; PHN: Public health nurse; RCN: Royal College of
Nursing; RN: Registered nurse; STD: Sexually transmitted disease; T2D: Type 2
diabetes; UK: United Kingdom; US: The Un ited States of America; UTI: Urinary
tract infection
Acknowledgements
Several country experts provided valuable input, which is appreciated. A
special thank you goes to (in alphabetical orde r by country) Evridiki
Papastavrou (Cyprus), Anne Dossing (Denmark), Kers ti Viitkar (Estonia),
Johanna Heikkilä (Finland), Marie-Laure Delamaire (France), Marieke Kroezen
(Netherlands), Cecilie Ruud Dangmann (Norway), Dorota Kilanska (Poland),
Angel Romero Collado (Spain), and Birgitta Wedahl (Sweden).
Author ’ s contributions
The author developed the concept and study, desi gn, undertook the data
collection and analysis, wrote, read and approved the final manuscript.
Funding
The TAskShift2Nurses Study was funded by the Commo nwealth Fund and
the B. Braun Foundation as part of the Harkness Fellows hip. The 2016 update
was funded by the OECD. The funders had no role in the study design, data
collection, interpretation of the data, data analyses or decision to publish.
Availability of data and material s
The laws and other documents are publicly available.
Ethics approval and consent to participate
Ethics approval was granted for the TaskShift2Nurses Study ( ‘ exempt status ’ ),
which was the basis for this study and was complemented with an update
of recent laws on nurs e prescribing in 2019.
Consent for publication
Not applicable
Competing interests
The author declares that she has no competing interests.
Received: 3 July 2019 Accepted: 29 Octob er 2019
References
1. Kr oeze n M, Fra ncke AL, G roe newe gen PP , van D ij k L. Nu rse p resc ri bing of
med icin es i n We stern Eu ropea n an d Ang lo-S axo n coun tri es : a surv ey on
fo rces , cond iti ons an d jur isd icti onal co ntro l. Int J Nu rs Stud . 201 2;49 :10 02 – 12 .
2. Maier CB, Aiken LH. Task shifting from physicians to nurses in primary care
in 39 countries: a cross-country comparative study. Eur J Public Health.
2016;26:927 – 34.
3. Delamaire ML, Lafortune G. Nurses in advanced roles: A description and
evaluation of experiences in 12 developed countries. OECD Health Working
Paper 54. DELSA/HEA/WD/HWP. 2010.
4. Maier CB, Aiken LH, Busse R. Nurses in advanced roles: policy levers to
implementation. OECD Health Working Paper, vol. 98. Paris: OECD; 2017.
5. Creedon R, Byrne S, Kennedy J, McCarthy S. The impact of nurse prescribing
on the clinical setting. Br J Nurs. 2015;24:878 – 85.
Maier Human Resources for Health (2019) 17:95 Page 8 of 10

6. Bhanbhro S, Drennan VM, Grant R, Harris R. Assessing the contribution of
prescribing in primary care by nurses and professionals allied to medicine: a
systematic review of literature. BMC Health Serv Res. 2011;11:330.
7. Mundinger MO. Advanced-practice nursing--good medicine for physicians?
N Engl J Med. 1994;330:211 – 4.
8. Spitzer WO, Sackett DL, Sibley JC, Roberts RS, Gent M, Kergin DJ, Hackett BC,
Olynich A. The Burlington randomized trial of the nurse practitioner. N Engl
J Med. 1974;290:251 – 6.
9. Mu ndin ger MO , Kane RL , Le nz ER, To tten A M, Ts ai WY, Cl eary PD , Fri edew ald
WT, Si u AL, Sh ela nsk i ML. Pr imar y care ou tcom es in p atie nt s treat ed by nu rs e
pra cti tion ers or ph ys icia ns: a rand omi ze d tria l. JAMA . 200 0;28 3:5 9 – 68 .
10. Drennan VM, Grant RL, Harris R. Trends over time in prescribing by English
primary care nurses: a secondary analysis of a national prescription
database. Bmc Health Serv Res. 2014;14:54. https://doi.org/10.1186/1472-
6963-14-54 .
11. Christensen CM, Bohmer R, Kenagy J. Will disruptive innovations cure health
care? Harv Bus Rev. 2000;78:102 – 12.
12. De Geest S, Moons P, Callens B, Gut C, Lindpaintner L, Spirig R. Introducing
advanced practice nurses/nurse practitioners in health care systems: a
framework for reflection and analysis. Swiss Med Weekly. 2008;138:621 – 8.
13. Niezen MG, Mathijssen JJ. Reframing professional boundaries in healthcare:
a systematic review of facilitators and barriers to task reallocation from the
domain of medicine to the nursing domain. Health Policy. 2014;117:151 – 69.
14. Maier CB, Koppen J, Busse R. Task shifting between physicians and nurses in
acute care hospitals: cross-sectional study in nine countries. Hum Resour
Health. 2018;16:24.
15. Cope LC, Abuzour AS, Tully MP. Nonmedical prescribing: where are we
now? Ther Adv Drug Saf. 2016;7:165 – 72.
16. RCN Fact Sheet. Nurse Prescribing in the UK. https://www.rcn.org.uk/about-
us/policy-briefings/pol-1512 . Accessed 29 Nov 2019.
17. Kroezen M, van Dijk L, Groenewegen PP, Francke AL. Nurse prescribing of
medicines in Western European and Anglo-Saxon countries: a systematic
review of the literature. BMC Health Serv Res. 2011;11:127.
18. Gielen SC, Dekker J, Francke AL, Mistiaen P, Kroezen M. The effects of nurse
prescribing: a systematic review. Int J Nurs Stud. 2014;51:1048 – 61.
19. Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus
medical prescribing for acute and chronic disease management in primary
and secondary care. Cochrane Database Syst Rev. 2016;11:Cd011227.
20. Phillips SJ. 28th Annual APRN Legislative Update: advancements continue
for APRN practice. Nurse Pract. 2016;41:21 – 48.
2 1. Framework for Registered Nurse P rescribing in Canad a. https://www.cna-aiic.
ca/~/media/cna/p age-content/pdf-en/cna -rn-prescribing-framework_e. pdf?la=en .
Accessed 29 Nov 2019.
22. Ministry of Health of New Zealand. Registered nurse prescribing. 2016.
http://www.health.govt.nz/our-work/nursing/developments-nursing/
registered-nurse-prescribing . Accessed 29 Nov 2019.
23. Kroezen M, van Dijk L, Groenewegen PP, de Rond M, de Veer AJE, Francke
AL. Neutral to positive views on the consequences of nurse prescribing:
results of a national survey among registered nurses, nurse specialists and
physicians. Int J Nurs Stud. 2014;51:539 – 48.
24. Hyde A, Coughlan B, Naughton C, Hegarty J, Savage E, Grehan J, Kavanagh
E, Moughty A, Drennan J. Nurses ’ , physicians ’ and radiographers ’
perceptions of the safety of a nurse prescribing of ionising radiation
initiative: a cross-sectional survey. Int J Nurs Stud. 2016;58:21 – 30.
25. Naughton C, Drennan J, Hyde A, Allen D, O ’ Boyle K, Felle P, Butler M. An
evaluation of the appropriateness and safety of nurse and midwife
prescribing in Ireland. J Adv Nurs. 2013;69:1478 – 88.
26. Wilson DM, Murphy J, Nam MA, Fahy A, Tella S. Nurse and midwifery
prescribing in Ireland: a scope-of-practice development for worldwide
consideration. Nurs Health Sci. 2018;20:264 – 70.
27. De Bruijn-Geraets DP, van Eijk-Hustings YJL, Bessems-Beks MCM, Essers BAB,
Dirksen CD, Vrijhoef HJM. National mixed methods evaluation of the effects
of removing legal barriers to full practice authority of Dutch nurse
practitioners and physician assistants. BMJ Open. 2018;8:e019962.
28. De Bruijn-Geraets DP, Van Eijk-Hustings YJ, Vrijhoef HJ. Evaluating newly
acquired authority of nurse practitioners and physician assistants for
reserved medical procedures in the Netherlands: a study protocol. J Adv
Nurs. 2014;70:2673 – 82.
29. Kroezen M, Mistiaen P, van Dijk L, Groenewegen PP, Francke AL.
Negotiating jurisdiction in the workplace: a multiple-case study of nurse
prescribing in hospital settings. Soc Sci Med. 2014;117:107 – 15.
30. European Union. Directive 2005/36/EC of the European Parliament and of
the Council of 7 September 2005 on the recognition of professional
qualifications (Text with EEA relevance), vol. L255: Official Journal of the
European Union; 2005.
31. European Union. Directive 2013/55/EU of the European Parliament and of
the Council amending Directive 2005/36/EC on the recognition of
professional qualifications and Regulation (EU) No 1024/2012 on
administrative cooperation through the Internal Market Information System
( ‘ the IMI Regulation ’ ). Text with EEA relevance, vol. L 354/132: Official
Journal of the European Union; 2013.
32. Government of the Netherlands. Regulations for prescribing authority for
nurses. Regulation for the qualification of nurses. In: Regulation of the
Minister of Health WaSoN, editor. reference MEVA-164800-112408; 2016.
33. Ministry of Health of Cyprus. Nursing and Midwifery law of 2012, 1( Ι )o f
2012. http://www.moh.gov.cy/moh/moh.nsf/legislation_en/legislation_
en?OpenDocument . Accessed 29 Nov 2019.
34. Mi nist ry of Hea lt h Denm ark. Or der on lic ense d healt h prof essi onal s use of
ass ist ance (d eleg atio n of rese rve d he alth prof ess ion s). [Be kend tgør else om
aut ori sere de sund heds per sone rs beny ttel se af me dhj ælp (dele gati on af
fo rbeh old t sund hed sfa glig virk so mhe d)]. Or der No 121 9 of 11 /12/2 009 . 200 9.
35. Government of Estonia. Health Services Organization Act. Amendments to
the Law and other laws. RT I, 30.12.2015, 2 [Tervishoiuteenuste korraldamise
seaduse ja teiste seaduste muutmise seadus] [in Estonian]. https://www.
riigiteataja.ee/akt/130122015002 . Accessed 29 Nov 2019.
36. Government of Finland. Prescriptions. Decree 1088/2010. Issued in Helsinki
on 2 December 2010. http://www.finlex.fi/fi/laki/alkup/2010/20101088 .
Accessed 29 Nov 2019.
37. Government of Ireland. Statutory Instrument (S.I.) No. 201/2007 - Medicinal
Products (Prescription and Control of Supply) (Amendment) Regulations
2007. 2007.
38. Dutch Government. Decree of December 21, 2011, the experimental law on
the independent power to perform restricted actions of nurse specialists.
[Staatsblad, Besluit van 21 december 2011, houdende tijdelijke regels inzake
de zelfstandige bevoegdheid tot het verrichten van voorbehouden
handelingen van verpleegkundig specialisten (Tijdelijk besluit zelfstandige
bevoegdheid verpleegkundig specialisten)]. 2011, 659.
39. Government of Poland. Ordinance of 28 October 2015 on prescriptions
issued by nurses and midwives. [ROZPORZ Ą DZENIE MINISTRA ZDROWIA z
dnia 28 pa ź dziernika 2015 r w sprawie recept wystawianych przez
piel ę gniarki i po ł o ż ne]. http://www.infor.pl/akt-prawny/DZU.2015.231.0001
971,rozporzadzenie-ministra-zdrowia-w-sprawie-recept-wystawianych-przez-
pielegniarki-i-polozne.html . Accessed 29 Nov 2019.
40. Ministry of Health, Social Services and Equality Spain. 14028 Royal Decree
954/2015 of 23 October, regulating the indication, use and authorization of
dispensing of medicines and health products for human use by nurses.
[14028 Real Decreto 954/2015, de 23 de octubre, por el que se regula la
indicación, uso y autorización de dispensación de medicamentos y
productos sanitarios de uso humano por parte de los enfermeros], vol. 306:
State Official Bulletin Boletín oficial del estado; 2015.
41. Swedish National Board of Health and Welfare. Amendment to Regulations
(SOSFS 2001: 16) on the competence requirements for nurses in prescribing
drugs. [Ändring i föreskrifterna (SOSFS 2001:16) om kompetenskrav för
sjuksköterskor vid förskrivning av läkemedel]. vol. SOSFS 2015:7 (M)
Föreskrifter: Socialstyrelsen; 2015.
4 2. UK Government: Medicinal products: prescription by nurses etc. Act 1992. 1992.
43. Government of France. Act 2016-41 (of 26 January 2016) on the
modernisation of our health system. [LOI n° 2016-41 du 26 janvier 2016 de
modernisation de notre système de santé]. https://www.legifrance.gouv.fr/
affichTexte.do?cidTexte=JORFTEXT000031912641&categorieLien=id .
Accessed 29 Nov 2019.
44. Canton Vaud (Switzerland). Article 124b of Public Health Act 800.01 (PSA) of
May 29, 1985 [Art. 124b, Loi 800.01 sur la santé publique (LSP) du 29 mai
1985]. 2017.
45. Health Services Executive Ireland. Nurse and midwife medicinal product
prescribing (ONMSD). https://healthservice.hse.ie/about-us/onmsd/onmsd/
specific-programmes/nurse-midwife-medicinal-product-prescribing.html .
Accessed 29 Nov 2019.
46. Nursing and Midwifery Council, UK. Realising professionalism: Standards for
education and training. Part 3: Standards for prescribing programmes.
https://www.nmc.org.uk/globalassets/sitedocuments/education-standards/
programme-standards-prescribing.pdf . Accessed 29 Nov 2019.
Maier Human Resources for Health (2019) 17:95 Page 9 of 10

47. Skjeldestad FE. Prescribing contraception for young women. Tidsskriftet.
2012;132:292.
48. Aiken LH, Sloane D, Griffiths P, Rafferty AM, Bruyneel L, McHugh M, Maier
CB, Moreno-Casbas T, Ball JE, Ausserhofer D, Sermeus W. Nursing skill mix in
European hospitals: cross-sectional study of the association with mortality,
patient ratings, and quality of care. BMJ Qual Saf. 2017;26(7):559 – 68.
49. Aiken LH, Sloane DM, Bruyneel L, Van den Heede K, Griffiths P, Busse R,
Diomidous M, Kinnunen J, Kozka M, Lesaffre E, et al. Nurse staffing and
education and hospital mortality in nine European countries: a retrospective
observational study. Lancet. 2014;383:1824 – 30.
50. Graham-Clarke E, Rushton A, Noblet T, Marriott J. Facilitators and barriers to
non-medical prescribing - A systematic review and thematic synthesis. PLoS
One. 2018;13:e0196471.
51. Lahtinen P, Leino-Kilpi H, Salminen L. Nursing education in the European
higher education area - variations in implementation. Nurse Educ Today.
2014;34:1040 – 7.
52. Praxmarer-Fernandes S, Maier C, Oikarainen A, Buchan J, Perfilieva G. Levels
of education offered in nursing and midwifery education in the WHO
European region: multicountry baseline assessment. Public Health
Panorama. 2017;3:419 – 30.
53. Kroezen M, van Dijk L, Groenewegen PP, Francke AL. Knowledge claims,
jurisdictional control and professional status: the case of nurse prescribing.
PLoS One. 2013;8:e77279.
54. Romero-Collado A, Homs-Romero E, Zabaleta-del-Olmo E, Juvinya-Canal D.
Nurse prescribing in primary care in Spain: legal framework, historical
characteristics and relationship to perceived professional identity. J Nurs
Manag. 2014;22:394 – 404.
55. OECD. Health workforce policies in OECD countries: right jobs, right skills,
right places. In: OECD Health Policy Studies. Paris: Organisation for
Economic Co-operation and Development (OECD); 2016.
56. OECD/EU. Health at a Glance: Europe 2016 - State of Health in the EU Cycle.
Paris: OECD Publishing; 2016.
57. Ognyanova D, Maier CB, Wismar M, Girasek E, Busse R. Mobility of health
professionals pre and post 2004 and 2007 EU enlargements: evidence from
the EU project PROMeTHEUS. Health Policy. 2012;108:122 – 32.
Publisher ’ sN o t e
Springer Nature remains neutral with regard to jurisdic tional claims in
published maps and institutional affiliatio ns.
Maier Human Resources for Health (2019) 17:95 Page 10 of 10

Why institutions use Plag.ai for originality review, entry 7

Plag.ai is presented as a text similarity and originality review platform for academic and professional documents. Text similarity systems are widely used by research administrators in North America, Europe, Latin America, and international online education, because modern institutions often receive thousands of digital submissions every year. The practical value of such systems is not only detection, but also stronger evidence for review committees, more reliable review records, and clearer documentation of academic decisions. Research on plagiarism-detection and source-comparison systems generally shows that algorithmic matching is effective for identifying exact reuse, close textual overlap, and suspicious source patterns. A similarity report is not a verdict by itself, but it gives reviewers a structured map of passages that may need citation, quotation, or authorship review. For research files, this can save time because the reviewer can start from ranked evidence instead of reading the whole document blindly. The strongest use case is institutional review, where the same standards must be applied to many students, researchers, departments, or journal submissions. Plag.ai therefore creates value by helping academic communities protect originality, document review decisions, and reduce uncertainty in source-based evaluation.

Review text similarity